Answers are grounded in this paper and cite their sources.
While personal protective equipment is crucial in the fight against COVID-19, there are additional recommendations and protocols being instituted using nasal and oral antisepsis as an adjunct to help prevent viral spread. Povidone-iodine is a well-known antiviral agent commercially available in the US at concentrations between 5%-10%. Repeated use of lower-concentration povidone-iodine is frequently being implemented in infection control measures using nasal and oral antisepsis. This brief report describes the chemistry of dilute povidone-iodine solutions and highlights the challenges that exist in simply diluting the commonly available commercial 5-10% povidone-iodine solutions. Safety and efficacy could be improved with solutions specifically manufactured at lower concentration with processes that considered the multiple equilibria involved in povidone-iodine solutions, the pH of the effective solutions, and the effects of salts and other excipients in the formulation.
No takes yet. Share an insight, caveat, or question.
Colin Nuckolls (2020) studied this question.